Although histone H3 Lys4 (H3K4) methylation is widely associated with gene activation, direct evidence for its causal role in transcription, through specific MLL family members, is scarce. Here we have purified a human MLL2 (Kmt2b) complex that is highly active in H3K4 methylation and chromatin transcription in a cell-free system. This effect requires S-adenosyl methionine and intact H3K4, thus establishing a direct and causal role for MLL2-mediated H3K4 methylation in transcription. We also show that human AKAP95, a chromatin-associated protein, physically and functionally associates with MLL complexes and directly enhances their methyltransferase activity. Ectopic AKAP95 stimulates expression of a chromosomal reporter gene in synergy with MLL1 or MLL2, whereas AKAP95 depletion impairs retinoic acid-mediated gene induction in embryonic stem cells. These results demonstrate an important role for AKAP95 in regulating histone methylation and gene expression, particularly during cell-fate transitions. npg 1 1 5 7 A r t i c l e s as a direct and new modulator of H3K4 methylation, a transcriptional coactivator and an important regulator of gene induction during ESC-fate transitions.
Histone modifications have been closely linked to many DNA-related processes 1 including transcription 2 . In particular, acetylation of histones H3 and H4 and methylation of H3K4, especially trimethylation, are prominent modifications related to active gene expression 3, 4 . The most notable H3K4 methyltransferases in mammals are the SET1 and MLL family complexes (hereafter called MLL complexes), which, apart from some specialized subunits, contain either hSET1A, hSET1B, MLL1, MLL2, MLL3 or MLL4 as the catalytic subunit and WDR5, RbBP5, ASH2L and DPY30 as integral core subunits that are necessary for the efficient methylation activity of the complexes [4] [5] [6] .
Numerous reports, based largely on chromatin immunoprecipitation (ChIP) assays, have shown a close association of H3K4 methylation with gene activation 7-10 , but the majority describe correlative, rather than causal, relationships. Two major lines of indirect evidence are consistent with a causal role for H3K4 methylation in gene activation. First, deletion or depletion of the catalytic or core subunits of the MLL complexes has been shown to affect H3K4 methylation and expression of specific genes 5, [11] [12] [13] [14] [15] [16] . Second, trimethylated H3K4 (H3K4me3) can be bound, through specific domains such as PHD fingers, by effector proteins ('readers') that are directly or indirectly involved in transcription, thus linking H3K4me3 to transcription 5, 17, 18 . Nonetheless, these lines of evidence are complicated by the following points: (i) noncatalytic activities of the methyltransferase may regulate gene expression, as exemplified by the action of MLL1 in promoting expression of a neurogenic gene (Dlx2) by recruitment of an H3K27 demethylase rather than by H3K4 methylation 19 ; (ii) nonhistone proteins can also be functional substrates for histonemodifying enzymes 20 including an H3K4 methyltransferase 21 ; (iii) in principle, methylated nonhistone proteins might also bind H3K4 methyl readers and lead to observed effects; and (iv) methyltransferases and methyl readers have many genomic targets, thus making it difficult to rigorously demonstrate, in cells, their direct effect on the specific genes of interest. Moreover, the establishment of a causal role for H3K4 methylation in transcription by histone gene mutation is also technically challenging in higher organisms, owing to the existence of multiple copies of individual histone genes.
To demonstrate a causal role for H3K4 methylation in transcription, we set out to purify and characterize a human MLL2 (Kmt2b, gene ID 9757) complex that was active in H3K4 methylation and chromatintemplated in vitro transcription. We then searched for new regulators of this modification that might be associated with the MLL2 complex as well as with other MLL complexes. We recently have shown that mammalian DPY30, a common subunit of all MLL complexes 22 , is important for efficient H3K4 methylation and transcriptional plasticity in embryonic stem cell (ESC) differentiation 23 . Using DPY30 as a bait, our current study has resulted in the isolation of MLL complexes that are associated with a new component, AKAP95.
AKAP95 is the only nuclear member of the large family of A-kinase anchoring proteins (AKAPs), which share a common function in protein kinase A (PKA) binding and spatiotemporal regulation of cellular signaling 24 . Among the many proposed roles of AKAP95 (refs. [25] [26] [27] , which include mediation of chromatin condensation 28, 29 , is a function in transcription regulation that is based on location in the nuclear matrix and binding to p68 RNA helicase 30 . However, direct evidence for a role in gene expression is lacking. Recently, AKAP95 was also found to interact with Oct4, a transcription factor crucial for ESC pluripotency 31 , but it is unclear whether AKAP95 is involved in ESC maintenance and differentiation. Here, we have established AKAP95
RESULTS

The MLL2 complex is highly active in methylating histone H3K4
We subjected nuclear extract derived from a HEK293 cell line that stably expresses Flag-and hemagglutinin (HA)-tagged full-length human MLL2 (Kmt2b) (FH-MLL2) to anti-Flag antibody-mediated immunoaffinity purification. As revealed by MS analysis, most of the co-purified proteins were known common subunits of the MLL1 and MLL2 complexes and included WDR5, RbBP5, ASH2L, DPY30 and menin ( Fig. 1a) . We confirmed an endogenous association of these proteins by their coimmunoprecipitation with MLL2 from HeLa-cell nuclear extract (Supplementary Fig. 1a ).
In an in vitro histone methyltransferase (HMT) assay, the MLL2 complex (MLL2C) showed strong H3 methylation activity on free histone octamers and both recombinant and native HeLa nucleosomal substrates ( Fig. 1b) . We detected no H3 methylation for a recombinant histone-octamer substrate carrying the H3K4Q mutation (although weak H2A and H2B methylation could be detected) or on a nucleosomal substrate carrying the H3K4Q mutation. Hence, the MLL2C methyltransferase activity is specific for H3K4. We further tested the activity of MLL2C on recombinant chromatin templates 32 assembled from a plasmid and histone octamers carrying either wild-type H3 or the H3K4Q mutant ( Fig. 1c) . Micrococcal nuclease (MNase) digestion of the two assembled chromatins produced indistinguishable DNA ladders of kinetic intermediates, a result indicating comparable assembly qualities for these two chromatin templates ( Fig. 1d) . MLL2C was shown to catalyze mono-, di-and trimethylation of H3K4 on chromatin assembled with wild-type H3 but not on chromatin assembled with the H3K4Q mutant ( Fig. 1d) . Interestingly, the histone acetyltransferase (HAT) p300 strongly enhanced MLL2Cdependent H3K4 methylation on the chromatin template, and this effect was evident for all three methylation states ( Fig. 1e) . Unlike the case for previously reported WDR5-MLL1 complex 12 , which associates with MOF, a MYST family HAT, no known or putative HAT was found in the purified MLL2 complex by the MS analysis. Consistent with this result, MLL2C failed to show any HAT activity ( Supplementary Fig. 1b) . Therefore, the MLL2 complex described above is highly active and specific for H3K4 methylation.
H3K4 methylation stimulates chromatin transcription
To test the role of MLL2C-mediated H3K4 methylation in transcription, we used a well-established chromatin-templated in vitro transcription system 32 with the same chromatin templates (Figs. 1c and 2a) used in the modification assays described above. As the template has a tandem repeat of five p53-responsive elements, we used p53 as the transcription activator and HeLa-cell nuclear extract as the source of RNA polymerase II, general transcription factors and Mediator 32 .
Addition of MLL2C had no detectable effect on p53-dependent transcription on a DNA template ( Fig. 2b, lanes 1-3) or on basal transcription (in the absence of p53) on the chromatin template ( Fig. 2b , lanes 4 and 5). In contrast, MLL2C showed a strong stimulatory effect on p53-dependent chromatin transcription that was comparable to the effect of p300 ( Fig. 2b , lanes 7-9), a previously established highly active transcription coactivator in this assay 33 . (Of note, the p53-dependent activity observed in the absence of added p300 or MLL2C, but in the presence of acetyl CoA and S-adenosyl methionine (SAM), probably reflects contributions of endogenous histone-modifying activities (Fig. 2b, lane 7 versus lane 4) ). Furthermore, MLL2C and p300 had a synergistic effect on chromatin transcription ( Fig. 2c , comparison of lanes 5, 8 and 9). The strong stimulatory effect of MLL2C was greatly reduced by omission of exogenous SAM from the reaction (Fig. 2c , lanes 5 and 6, and Supplementary Fig. 1c , lanes 3 and 4), thus indicating that MLL2C-mediated transcription enhancement depends on its methyltransferase activity. Importantly, although having a minimal effect on the transcription without exogenous MLL2C (Fig. 2d , lanes 3 and 4), the H3K4Q mutation almost completely abolished the otherwise strong stimulatory effect of MLL2C on transcription ( Fig. 2d A r t i c l e s methylation of H3K4, rather than possible nonhistone substrates, in transcription. Notably, p300 alone had equally strong effects on transcription from the wild-type H3 and H3K4Q chromatin templates ( Fig. 2d , comparison of lanes 7 and 8), thus indicating the retention of the overall integrity of the mutant chromatin and the lack of any contribution of an endogenous H3K4 methyltransferase activity in the nuclear extract to the p300-dependent transcription stimulation. Hence, these results unambiguously demonstrate a direct causal role for MLL2C-mediated H3K4 methylation in transcription activation, including its synergistic function with p300. One interesting observation from our transcription experiments is the acetyl CoA dependence of MLL2C-mediated transcription stimulation ( Fig. 2c , lanes 4-7 and Supplementary Fig. 1c , lanes 2-5).
To determine whether acetylation of histones, rather than other nonhistone factors, has an important role in H3K4 methylation-mediated transcription, we performed transcription assays on chromatin templates containing either wild-type histones or histones with specific lysine mutations in H3 (K14R K18R) and H4 (K5R K8R) ( Fig. 2e) . These lysine residues are known to be acetylated by p300 (ref. 34) and potentially by other HATs. We found that mutations in H3 or H4 alone partially impaired, and simultaneous mutations in both H3 and H4 completely abolished, the transcription-stimulatory effect of MLL2C ( Fig. 2f , lanes 9-12). Importantly, these histone mutations barely affected the low-level transcription observed in the absence of MLL2C (Fig. 2f , lanes 5-8) or the MLL2C-mediated H3K4 methylation of chromatin ( Supplementary Fig. 1d ), results indicative of the overall integrity of chromatins containing mutated histones. Taken together, these results indicate that lysine acetylation of histone H3 and H4 is essential for manifestation of the stimulatory effect of MLL2C-mediated H3K4 methylation on transcription.
AKAP95 is associated with DPY30−MLL complexes
To identify new proteins associated with MLL2C and other MLL complexes, we prepared nuclear extract from a HEK293 cell line that stably expresses Flag-HA-tagged human DPY30 and subjected it to an immunoaffinity purification and subsequent MS analysis. In addition to the established subunits of MLL family complexes, AKAP95 was identified as one of the major DPY30-associated proteins ( Fig. 3a) , as further confirmed by immunoprecipitation with anti-HA antibody and immunoblotting ( Supplementary Fig. 2a ). Components of the NURF complex 35 were also found to be associated with DPY30 ( Fig. 3a) but were not pursued in this study. An endogenous association of AKAP95 with DPY30 was confirmed by their coimmunoprecipitation from HeLa nuclear extract by an antibody to DPY30 (Fig. 3b) . As further evidence that more rigorously establishes AKAP95 as a bona fide binding partner of DPY30 in the context of MLL complexes: (i) immunoprecipitation of WDR5 or ASH2L efficiently coprecipitated AKAP95 ( Fig. 3c and Supplementary Fig. 2b) ; (ii) epitope-tagged AKAP95 also efficiently coprecipitated ASH2L and WDR5 ( Supplementary Fig. 2c ); and (iii) a gel-filtration chromatography analysis revealed co-elution of AKAP95 with the MLL1 and MLL2 complexes but not with the abundant dimerized or free DPY30 ( Fig. 3d ).
AKAP95 stimulates expression of a chromosomal reporter gene
The physical interaction between AKAP95 and DPY30-MLL complexes raised the possibility of their functional relevance in regulating gene expression. In a HEK293T cell line (G-293T) that contains a chromosomally integrated luciferase reporter gene with upstream Gal4-binding sites 23 , overexpression of AKAP95 strongly stimulated the expression of reporter RNA and possibly protein (indirectly indicated by the luciferase activity); this effect was critically dependent upon the presence and dose of the Gal4-VP16 activator ( Fig. 4a and Supplementary Fig. 3a,b) . Remarkably, AKAP95 showed strong synergy with either MLL1 or MLL2 in stimulating reporter gene expression ( Fig. 4a,b) . Furthermore, overexpression of either AKAP95 or MLL2 markedly enhanced the levels of dimethylated H3K4 (H3K4me2) and H3K4me3 at the promoter region of the chromosomal Gal4-luciferase locus (Fig. 4c) , results strongly suggesting effects at the transcriptional level. (d) Autoradiographic analysis of in vitro transcription on chromatin templates assembled with histone octamers containing wild-type H3 or H3K4Q mutant. (e) Illustration of specific H3 and H4 lysine residues (red) that were mutated to arginine in f. (f) Autoradiographic analysis of in vitro transcription on chromatin templates assembled with histone octamers containing wild-type H3 or H3 (K14R K18R) mutant and wild-type H4 or H4 (K5R K8R) mutant, as indicated. Mut, mutant. p300 was not added in any of the reactions. npg A r t i c l e s Coactivation requires the DPY30-binding region of AKAP95 By serial truncations from N and C termini ( Fig. 5a) , we mapped the AKAP95 regions that are important for its transcriptional stimulatory activity in the chromosomal reporter assay. AKAP95 (residues 1-210 and 1-340) were inactive in enhancing reporter expression ( Fig. 5b) . AKAP95(1-530), despite its very low expression level, modestly enhanced luciferase expression in a dose-dependent manner and was thus considered active ( Fig. 5c ). Despite their high levels of expression, AKAP95(341-692), AKAP95(211-692) and AKAP95(101-692) all failed to enhance reporter expression ( Fig. 5b,c) , thus indicating an essential role of the N-terminal region (residues 1-100) in this AKAP95 function. In a further analysis, we found that the nuclear localization signal (NLS) and the two zinc fingers, but not the nuclear matrix targeting site 30 or the RII-binding domain, were important for enhancement of reporter expression ( Fig. 5d and Supplementary   Fig. 3c ). Because deletion of the RII-binding region led to poor expression, we tested an AKAP95 point mutant (I582P) that was previously shown to disrupt the binding of AKAP95 to RII 36 and found it to have only a little or marginal effect on AKAP95 activity (Supplementary Fig. 3c) , thus suggesting that binding to PKA RII is not critical for AKAP95 coactivation of reporter expression.
We also tested the truncated AKAP95 proteins for binding to DPY30 after coexpression in G-293T cells. AKAP95(1-210), but not AKAP95(101-692), was sufficient for binding ( Fig. 5e) . Thus, the N-terminal region (residues 1-100), which is important for enhancing reporter expression, is also critical for binding to DPY30. Although not as effective in binding AKAP95 as is endogenous DPY30 in HeLa-cell nuclear extract, purified DPY30 showed considerable binding to purified AKAP95 and much weaker binding to purified AKAP95(101-692), thus demonstrating a direct binding that depends 
npg
A r t i c l e s on the N-terminal region of AKAP95 ( Fig. 5f) . Importantly, truncation of this N-terminal region is unlikely to affect the overall structural integrity of AKAP95, as (i) AKAP95(387-692), which lacks the more extensive N-terminal region, was reported to retain full activity in mediating chromatin condensation 37 , and (ii) in the presence of the activator, recruitment to the reporter gene promoter was somewhat greater for AKAP95(101-692) than for the less well-expressed AKAP95 but was comparable to that previously reported 23 for DPY30 ( Fig. 5c,g) . The efficient enrichment of AKAP95(101-692) also suggests that recruitment of AKAP95 to chromatin is independent of its binding to MLL complexes.
AKAP95 enhances the HMT activity of the MLL2 complex
We next tested whether AKAP95 has any direct effect on the HMT activity of MLL complexes. We expressed recombinant Flag-HAtagged AKAP95 and AKAP95(101-692) proteins, purified them to near homogeneity ( Fig. 6a) and analyzed them in the HMT assay on chromatin assembled with recombinant histone octamers and plasmid DNA. AKAP95, but not a comparable amount of AKAP95(101-692), markedly enhanced MLL2C-mediated H3 methylation on the chromatin substrate ( Fig. 6b and Supplementary Fig. 4a ). Further immunoblot analyses revealed that H3K4 mono-, di-and trimethylation were all enhanced by AKAP95 ( Fig. 6c) . Purified full-length and mutant AKAP95 did not possess methyltransferase activity (Fig. 6d , lanes 5 and 6; also shown in Supplementary Fig. 4b, lane 3) and were not associated with free histone H3 (Fig. 6d , lanes 8 and 9; also shown in Supplementary Fig. 4b, lane 4) , a good substrate for MLL2C. These results suggest that AKAP95, probably through binding DPY30, directly stimulates the enzymatic activity of the MLL2 complex. These data are also consistent with the pronounced effects of AKAP95 overexpression on H3K4 methylation at the chromosomal reporter locus. A r t i c l e s
AKAP95 regulates gene expression in ESC differentiation
Given the physical and functional interactions of AKAP95 and DPY30-MLL complexes, we tested whether AKAP95 might have a role in the all-trans retinoic acid (ATRA)-mediated induction of developmental genes in human embryonic carcinoma cells (ECCs) and mouse embryonic stem cells, as demonstrated by DPY30 (ref. 23 ). We effectively depleted AKAP95 from NT2 cells, a human ECC line (Fig. 7a) , and then treated the cells with ATRA. Several developmental genes, including IGFBP5, HAND1 and MSX1, were strongly induced in control cells upon ATRA treatment, but induction in each case was clearly impaired by AKAP95 depletion (Fig. 7b) . These results indicate an important role for AKAP95 in ATRA-mediated gene induction in human ECCs. We further explored the in vivo function of AKAP95 in the E14 mouse ESC line. Depletion of AKAP95 by two different short hairpin RNAs (shRNAs) (Fig. 7a) had little effect on ESC morphology (except that the cells appeared to be slightly more aggregated) ( Supplementary Fig. 5a ) or on proliferation rate (Supplementary Fig. 5b ) or expression levels of many important pluripotency genes (Supplementary Fig. 5c ). These results suggest that AKAP95 depletion does not affect self-renewal (and chromatin condensation) of mouse ESCs. AKAP95 depletion also did not affect the global H3K4me3 level, the expression of most genes by microarray analysis (data not shown) or the recruitment of DPY30 to any highly expressed or bivalent genes that were tested in ESCs (Supplementary Fig. 5d) . These results suggest that the coactivation function of AKAP95, similar to that of DPY30-mediated H3K4 methylation 23 , is obscured by potentially redundant mechanisms in undifferentiated ESCs. However, after ATRA-mediated differentiation, and as revealed both by quantitative PCR (qPCR) on selected genes (Fig. 7c) and by global expression analysis (Fig. 7d) , many genes involved in early development showed strong induction in the control cells but greatly impaired induction in AKAP95-depleted cells. Consistent with a stimulatory effect of AKAP95 on the enzymatic activity of MLL complexes, the ATRA-mediated increase of H3K4me3 on these target gene loci was diminished by AKAP95 knockdown (Fig. 7e) .
Further analyses of the microarray results for AKAP95 depletion and DPY30 or RbBP5 depletion 23 in ESCs have revealed related as well as divergent relationships between AKAP95 and MLL2C core subunits. As few genes were significantly affected by either depletion before ESC differentiation, we analyzed effects on the post-ATRA gene expression levels. We found a highly statistically significant overlap in the number of genes whose post-ATRA expression levels were affected over two-fold (or 1.5-fold) by depletion of AKAP95 or DPY30, although this overlap was less significant than the overlap indicated between depletion of RbBP5 or DPY30 ( Fig. 7f and Supplementary  Fig. 6) . These results suggest that AKAP95, although not an integral core subunit of MLL complexes as are DPY30 or RbBP5, is clearly functionally associated with DPY30 in co-regulating a set of common target genes. Gene ontology analyses have revealed that the genes (Supplementary Fig. 7a ) or AKAP95 ( Supplementary  Fig. 7b ) are enriched in developmental processes, especially in neuronal differentiation. These results suggest a common role for these genes in mediating ATRA-dependent neuronal specification of mouse ESCs. Whereas DPY30 and RbBP5 co-dependent genes are highly enriched in transcriptional regulatory functions (Supplementary Fig. 7c) , AKAP95-dependent genes and AKAP95 and DPY30 co-dependent genes are highly enriched in extracellular matrix and signaling pathways (Supplementary Fig. 7b,d) . The genes coaffected by depletion of AKAP95, DPY30 or RbBP5 are also enriched in both extracellular matrix and transcription regulation (Supplementary Fig. 7e) . These results suggest that AKAP95 and MLL-complex core subunits regulate ATRA-mediated differentiation in a coordinated yet differential manner on their targets in ESCs.
DISCUSSION
Starting with the isolation of a highly active MLL2C and continuing with characterization of its role in chromatin transcription in a cell-free system, we have gone further to identify and to functionally characterize a new factor associated with DPY30-MLL complexes. Our studies establish a clear causal role for H3K4 methylation by MLL2 in gene activation and, most notably, describe the function of a newly discovered modulator (AKAP95) of MLL-mediated H3K4 methylation.
MLL2 complex as a highly active H3K4 methyltransferase
A catalytically active WDR5-tagged MLL1 complex was previously shown to enhance transcription on a chromatin template 12 , but it was not shown that this effect was through methylation of H3K4 (versus a nonhistone substrate), and further experimentation was impeded by the relatively weak H3-methylation activity of the complex. Although difficult to normalize according to the amount of the catalytic subunit, the currently described MLL2C was empirically much more active in our analyses than were the isolated MLL1 (ref. 12 ) and MLL3 and MLL4 (ref. 38 ) complexes in methylating all levels of substrates (data not shown), potentially owing either to an enhanced occupancy of the catalytic subunit in the isolated complex or to an intrinsic difference between MLL2 and other MLL family members. As discussed below, the high activity of the MLL2C may be a key factor in helping to reveal an effect of H3K4 methylation on transcription. The lack of any detectable HAT in the purified MLL2 complex, compared to that in the previously purified WDR5-MLL1 complex that was associated with MOF 12 , could result from the different tagging and purification strategies or from MLL1 and MLL2 sequence variations that result in differential binding capabilities.
Direct coactivation of transcription by H3K4 methylation
The strict requirement for SAM and an intact H3K4 residue in the chromatin template for the stimulatory effect of the MLL2C in transcription unambiguously demonstrates a causal role for H3K4 methylation per se in activator-dependent transcription. This conclusion is corroborated by our cell-based studies showing that overexpression of either MLL1 or MLL2 strongly stimulates chromosomal reporter gene expression 23 . Although a previous report failed to show an effect of H3K4 methylation on transcription of a chromatin template 39 , this may have reflected either a low efficiency of methylation in the completely defined in vitro system that was used or, as is more likely, the absence in this system of transcription-related effector proteins that recognize H3K4 methylation. This contrasts with the present analysis in which the recombinant chromatin template was efficiently methylated by the MLL2C and transcribed in a nuclear extract that should contain previously described effectors for H3K4 methyl marks 18 . Consistent with this interpretation, recent studies have shown effects of an H3K4 trimethyl analog on transcription in a HeLa nuclear extract-based assay, through CHD1 (ref. 40 ) and TAF3 (ref. 41) as effectors.
Our cell-free H3K4 methylation and transcription system now offers an ideal platform for the analysis of factors and mechanisms underlying H3K4 methylation-dependent transcription, including factors that generate or regulate methylation and factors (effectors) that read the H3K4 methyl marks. This could involve either an unbiased biochemical fractionation and factor purification or systematic analyses of factors already shown to enhance H3K4 methylation or to recognize the H3K4 trimethyl mark. Indeed, our initial results suggest an important role for histone lysine acetylation in MLL2Cdependent and H3K4 methylation-dependent transcription that needs to be further explored. Furthermore, our new findings of an enhancement of MLL2C-mediated H3K4 mono-, di-and trimethylation by p300 ( Fig. 1e) and synergy between MLL2C and p300 in transcription (Fig. 2c) establish a new link between enzymes responsible for 'writing' two prevalent histone marks associated with gene activation. These results complement those of recent studies showing an enhancement of SET1C-mediated H3K4 methylation and associated p53-dependent transcription by p300 (ref. 42 ).
Association of AKAP95 with DPY30-MLL complexes
As DPY30 is shared among all MLL complexes, it is possible, but has not been rigorously demonstrated, that AKAP95 may also be commonly associated with all MLL complexes. Our discovery of AKAP95 as a bona fide partner and regulator of DPY30-MLL complexes has provided a new example of a protein factor, other than the wellestablished core subunits, that directly modifies the enzymatic activity of the H3K4 methyltransferases. Most of the known AKAPs bind specifically to PKA through the dimerization domain of the RII subunit 43 . Interestingly, the sequence of the DPY30 dimerization domain shares a striking homology to the RII dimerization domain (Fig. 7g) . Hence, it might be expected that a nuclear AKAP would actually associate with DPY30, although the regions on AKAP95 responsible for binding DPY30 and RII seem to be different. The molecular mechanism by which AKAP95 directly regulates the catalytic activity of the MLL2 complex is not clear and merits further biophysical studies. It will also be interesting to examine whether AKAP95 directly enhances H3K4 methylation mediated by other MLL complexes.
A role for AKAP95 in gene expression
A role for AKAP95 in gene regulation has been established by in vitro and in vivo results in this work. How does AKAP95 enhance chromosomal transcription? Primarily, three AKAP95 regions, including the NLS, the two zinc fingers and the N-terminal region (residues 1-100), have been found to be important for this activity. The NLS requirement suggests that AKAP95 affects transcription in the nucleus. The exact role of AKAP95 zinc fingers in regulating transcription is not clear, but they might facilitate association of AKAP95 with chromatin or transcription-related proteins, similarly to their reported roles in mediating chromosome condensation through chromatin binding and condensin recruitment 37 . The AKAP95 N-terminal region is required for AKAP95-enhanced transcription, and it is also critical for AKAP95 binding to DPY30 and for stimulation of the methylation activity of the DPY30-MLL2 complex. Our data, therefore, are consistent with a model in which AKAP95 enhances gene expression through binding and modulation of the activity of DPY30-MLL complexes, but this does not exclude other possible mechanisms. The related yet divergent relationship between AKAP95 and MLL complexes is underscored by their impact on ATRA-mediated gene induction in ESCs. Lineage npg A r t i c l e s specification for ESCs involves signaling pathways (including extracellular ligand-cellular receptor interactions) eventually transduced to instruct nuclear transcription regulation, and our analyses suggest that AKAP95 and MLL core subunits may preferentially focus on different parts of the system, in addition to co-regulating many common targets, to coordinate the ESC-fate transition. Our findings allow us to foresee a role for AKAP95 in coordinating transcription by serving as a platform for the docking and integration of H3K4 methyltransferases together with other potential transcription-related factors, analogously to the function of other AKAPs in organizing kinase and signaling molecules for a spatiotemporal regulation of signal transduction (Fig. 7g) . In this regard, it is particularly interesting that the DPY30 dimerization domain bears a striking homology to the otherwise unrelated PKA RII dimerization domain, with each domain mediating an association between an AKAP protein and an enzymatic activity specific for a distinct chemical modification (methylation versus phosphorylation) ( Fig. 7g) . It thus appears that nature has adopted similar strategies for two important but distinct biological processes.
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